Subscribe
shutterstock_1651313599_dcstockphotography
DCStockPhotography / Shutterstock.com
24 October 2023MedtechLiz Hockley

Fed Circ contests PTAB over single or plural meaning in microfluidic device patent

Judges partially overturn decision that ABS had failed to prove claims in Cytonome patent were invalid | PTAB and appeals court differ in interpretation of whether claims language had single or plural meaning.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Medtronic faces patent review revival as Fed Cir faults PTAB
11 July 2023   Precedential decision marks blow for medical device maker after earlier win | PTAB criticised for “fundamental legal error” and “narrow definition”.
Americas
Axonics v Medtronic: Fed Circ addresses PTAB ‘errors’
17 August 2023   A recent precedential case highlights the thorny issue of what constitutes a fair response to new claim constructions following an institution, says Blair Jacobs of McKool Smith.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Americas
Axonics v Medtronic: Fed Circ addresses PTAB ‘errors’
17 August 2023   A recent precedential case highlights the thorny issue of what constitutes a fair response to new claim constructions following an institution, says Blair Jacobs of McKool Smith.
Americas
Medtronic faces patent review revival as Fed Cir faults PTAB
11 July 2023   Precedential decision marks blow for medical device maker after earlier win | PTAB criticised for “fundamental legal error” and “narrow definition”.

More on this story

Americas
Axonics v Medtronic: Fed Circ addresses PTAB ‘errors’
17 August 2023   A recent precedential case highlights the thorny issue of what constitutes a fair response to new claim constructions following an institution, says Blair Jacobs of McKool Smith.
Americas
Medtronic faces patent review revival as Fed Cir faults PTAB
11 July 2023   Precedential decision marks blow for medical device maker after earlier win | PTAB criticised for “fundamental legal error” and “narrow definition”.

More features

Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York
UPC deals further blow to Dexcom in glucose monitor dispute with Abbott
‘A marathon and a sprint at the same time’: How we won $452m damages